Mechanochemical reaction of sulfathiazole with carboxylic acids: Formation of a cocrystal, a salt, and coamorphous solids

Crystal Growth and Design

Volumn 14, Issue 2, 2014, Pages 803-813

  Hu, Yun ^a   Gniado, Katarzyna ^a   Erxleben, Andrea ^a   McArdle, Patrick ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ATTENUATED TOTAL REFLECTANCE INFRARED; CO-CRYSTAL FORMATION; DL-MALIC ACID; GLUTARIC ACID; MECHANOCHEMICAL REACTIONS; POWDER X-RAY DIFFRACTION (PXRD); PRINCIPAL COMPONENTS ANALYSIS; STRONGEST ACID;

INFRARED DEVICES; ORGANIC ACIDS; OXALIC ACID; X RAY DIFFRACTION;

PRINCIPAL COMPONENT ANALYSIS;

EID: 84893694714     PISSN: 15287483     EISSN: 15287505     Source Type: Journal    
DOI: 10.1021/cg401673z     Document Type: Article

References (48)

1. Masuda, T.; Yoshihashi, Y.; Yonemochi, E.; Fujii, K.; Uekusa, H.; Terada, K. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir Int. J. Pharm. 2012, 422 (1-2) 160-169
2. Thakuria, R.; Delori, A.; Jones, W.; Lipert, M. P.; Roy, L.; Rodríguez-Hornedo, N. Pharmaceutical cocrystals and poorly soluble drugs Int. J. Pharm. 2013, 453 (1) 101-125
3. See US FDA GRAS List. http://www.fda.gov/food/ ingredientspackaginglabeling/gras/default.htm.
4. Brittain, H. G. Pharmaceutical cocrystals: The coming wave of new drug substances J. Pharm. Sci. 2013, 102 (2) 311-317
5. Qiao, N.; Li, M.; Schlindwein, W.; Malek, N.; Davies, A.; Trappitt, G. Pharmaceutical cocrystals: An overview Int. J. Pharm. 2011, 419 (1-2) 1-11
6. Lu, E.; Rodriguez-Hornedo, N.; Suryanarayanan, R. A rapid thermal method for cocrystal screening CrystEngComm 2008, 10 (6) 665-668
7. Löbmann, K.; Laitinen, R.; Grohganz, H.; Gordon, K. C.; Strachan, C.; Rades, T. Coamorphous Drug Systems: Enhanced Physical Stability and Dissolution Rate of Indomethacin and Naproxen Mol. Pharmaceutics 2011, 8 (5) 1919-1928
8. Löbmann, K.; Strachan, C.; Grohganz, H.; Rades, T.; Korhonen, O.; Laitinen, R. Co-amorphous simvastatin and glipizide combinations show improved physical stability without evidence of intermolecular interactions Eur. J. Pharm. Biopharm. 2012, 81 (1) 159-169
9. Chieng, N.; Aaltonen, J.; Saville, D.; Rades, T. Physical characterization and stability of amorphous indomethacin and ranitidine hydrochloride binary systems prepared by mechanical activation Eur. J. Pharm. Biopharm. 2009, 71 (1) 47-54
10. Braga, D.; Giaffreda, S. L.; Grepioni, F.; Pettersen, A.; Maini, L.; Curzi, M.; Polito, M. Mechanochemical preparation of molecular and supramolecular organometallic materials and coordination networks Dalton Trans. 2006, 10, 1249-1263
11. Trask, A.; Jones, W. Crystal Engineering of Organic Cocrystals by the Solid-State Grinding Approach. In Organic Solid State Reactions; Toda, F., Ed.; Springer: Berlin Heidelberg: 2005; Vol. 254, pp 41-70. (Pubitemid 44420828)
12. Trask, A. V.; van de Streek, J.; Motherwell, W. D. S.; Jones, W. Achieving Polymorphic and Stoichiometric Diversity in Cocrystal Formation: Importance of Solid-State Grinding, Powder X-ray Structure Determination, and Seeding Cryst. Growth Des. 2005, 5 (6) 2233-2241 (Pubitemid 41619316)
13. Yamamoto, K.; Tsutsumi, S.; Ikeda, Y. Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals Int. J. Pharm. 2012, 437 (1-2) 162-171
14. Lin, H.-L.; Zhang, G.-C.; Hsu, P.-C.; Lin, S.-Y. A portable fiber-optic Raman analyzer for fast real-time screening and identifying cocrystal formation of drug-coformer via grinding process Microchem. J. 2013, 110 (0) 15-20
15. Chieng, N.; Hubert, M.; Saville, D.; Rades, T.; Aaltonen, J. Formation Kinetics and Stability of Carbamazepine-Nicotinamide Cocrystals Prepared by Mechanical Activation Cryst. Growth Des. 2009, 9 (5) 2377-2386
16. Lin, S.-Y.; Hsu, C.-H.; Ke, W.-T. Solid-state transformation of different gabapentin polymorphs upon milling and co-milling Int. J. Pharm. 2010, 396 (1-2) 83-90
17. Balani, P. N.; Ng, W. K.; Tan, R. B. H.; Chan, S. Y. Influence of excipients in comilling on mitigating milling-induced amorphization or structural disorder of crystalline pharmaceutical actives J. Pharm. Sci. 2010, 99 (5) 2462-2474
18. Curtin, V.; Amharar, Y.; Hu, Y.; Erxleben, A.; McArdle, P.; Caron, V.; Tajber, L.; Corrigan, O. I.; Healy, A. M. Investigation of the Capacity of Low Glass Transition Temperature Excipients to Minimize Amorphization of Sulfadimidine on Comilling Mol. Pharmaceutics 2012, 10 (1) 386-396
19. Brittain, H. G. Polymorphism and solvatomorphism 2010 J. Pharm. Sci. 2012, 101 (2) 464-484
20. Anwar, J.; Tarling, S. E.; Barnes, P. Polymorphism of sulfathiazole J. Pharm. Sci. 1989, 78 (4) 337-342 (Pubitemid 19171932)
21. Apperley, D. C.; Fletton, R. A.; Harris, R. K.; Lancaster, R. W.; Tavener, S.; Threlfall, T. L. Sulfathiazole polymorphism studied by magic-angle spinning NMR J. Pharm. Sci. 1999, 88 (12) 1275-1280
22. Bingham, A. L.; Hughes, D. S.; Hursthouse, M. B.; Lancaster, R. W.; Tavener, S.; Threlfall, T. L. Over one hundred solvates of sulfathiazole Chem. Commun. 2001, 0 (7) 603-604 (Pubitemid 32291294)
23. McIntosh, J.; Robinson, R. H. M.; Selbie, F. R. Acridine-Sulphonamide Compounds As Wound Antiseptics Clinical Trials of Flavazole Lancet 1945, 246 (6361) 97-99
24. Abu Bakar, M. R.; Nagy, Z. K.; Rielly, C. D.; Dann, S. E. Investigation of the riddle of sulfathiazole polymorphism Int. J. Pharm. 2011, 414 (1-2) 86-103
25. Munroe, á.; Rasmuson, Å. C.; Hodnett, B. K.; Croker, D. M. Relative Stabilities of the Five Polymorphs of Sulfathiazole Cryst. Growth Des. 2012, 12 (6) 2825-2835
26. Caira, M. R. Sulfa Drugs as Model Cocrystal Formers Mol. Pharmaceutics 2007, 4 (3) 310-316 (Pubitemid 46983947)
27. Allen, F. The Cambridge Structural Database: a quarter of a million crystal structures and rising Acta Crystallogr., Sect. B 2002, 58 (3 Part 1) 380-388 (Pubitemid 135702674)
28. Lu, T.; Chen, C. Uncertainty evaluation of humidity sensors calibrated by saturated salt solutions Measurement 2007, 40 (6) 591-599 (Pubitemid 46829482)
29. Sheldrick, G. A short history of SHELX Acta Crystallogr., Sect. A 2008, 64 (1) 112-122
30. McArdle, P.; Gilligan, K.; Cunningham, D.; Dark, R.; Mahon, M. A method for the prediction of the crystal structure of ionic organic compounds-the crystal structures of o-toluidinium chloride and bromide and polymorphism of bicifadine hydrochloride CrystEngComm 2004, 6 (53) 303-309 (Pubitemid 40464471)
31. McArdle, P.; Hu, Y.; Lyons, A.; Dark, R. Predicting and understanding crystal morphology: the morphology of benzoic acid and the polymorphs of sulfathiazole CrystEngComm 2010, 12 (10) 3119-3125
32. McArdle, P. J. Appl. Crystallogr. 1995, 28, 65
33. Granovsky, A. A. Firefly (previously PC GAMESS). http://classic.chem.msu. su/gran/firefly/index.html.
34. Schmidt, M. W.; Baldridge, K. K.; J.A.Boatz, J. A.; Elbert, S. T.; Gordon, M. S.; Jensen, J. H.; Koseki, S.; atsunaga, N.; Nguyen, K. A.; Su, S.; Windus, T. L.; Dupuis, M.; Montgomery, J. A. J. Comput. Chem. 1993, 14, 1347-1363
35. Blagden, N.; J. Davey, R.; F. Lieberman, H.; Williams, L.; Payne, R.; Roberts, R.; Rowe, R.; Docherty, R. Crystal chemistry and solvent effects in polymorphic systems Sulfathiazole J. Chem. Soc., Faraday Trans. 1998, 94 (8) 1035-1044 (Pubitemid 128774389)
36. Gelbrich, T.; Hughes, D. S.; Hursthouse, M. B.; Threlfall, T. L. Packing similarity in polymorphs of sulfathiazole CrystEngComm 2008, 10 (10) 1328-1334
37. Hu, Y.; Erxleben, A.; Hodnett, B. K.; Li, B.; McArdle, P.; Rasmuson, Å. C.; Ryder, A. G. Solid-state Transformations of Sulfathiazole Polymorphs: the Effects of Milling and Humidity Cryst. Growth Des. 2013, 13, 3404-3413
38. Etter, M. C. Encoding and decoding hydrogen-bond patterns of organic compounds Acc. Chem. Res. 1990, 23 (4) 120-126
39. Zhang, S.; Rasmuson, Å. C. Thermodynamics and Crystallization of the Theophylline-Glutaric Acid Cocrystal Cryst. Growth Des. 2013, 13 (3) 1153-1161
40. Van Eerdenbrugh, B.; Taylor, L. S. Application of mid-IR spectroscopy for the characterization of pharmaceutical systems Int. J. Pharm. 2011, 417 (1-2) 3-16
41. Childs, S. L.; Stahly, G. P.; Park, A. The Salt-Cocrystal Continuum: The Influence of Crystal Structure on Ionization State Mol. Pharmaceutics 2007, 4 (3) 323-338 (Pubitemid 46983949)
42. Braga, D.; Giaffreda, S. L.; Grepioni, F.; Chierotti, M. R.; Gobetto, R.; Palladino, G.; Polito, M. Solvent effect in a "solvent free" reaction CrystEngComm 2007, 9 (10) 879-881
43. Trask, A. V.; Haynes, D. A.; Motherwell, W. D. S.; Jones, W. Screening for crystalline salts via mechanochemistry Chem. Commun. 2006, 1, 51-53
44. McHugh, C.; Erxleben, A. Supramolecular Structures and Tautomerism of Carboxylate Salts of Adenine and Pharmaceutically Relevant N6-Substituted Adenine Cryst. Growth Des. 2011, 11 (11) 5096-5104
45. Losev, E. A.; Mikhailenko, M. A.; Achkasov, A. F.; Boldyreva, E. V. The effect of carboxylic acids on glycine polymorphism, salt and co-crystal formation. A comparison of different crystallisation techniques New J. Chem. 2013, 37 (7) 1973-1981
46. Grisedale, L. C.; Belton, P. S.; Jamieson, M. J.; Barker, S. A.; Craig, D. Q. M. An investigation into water interactions with amorphous and milled salbutamol sulphate: The development of predictive models for uptake and recrystallization Int. J. Pharm. 2012, 422 (1-2) 220-228
47. Chattoraj, S.; Bhugra, C.; Telang, C.; Zhong, L.; Wang, Z.; Sun, C. Origin of Two Modes of Non-isothermal Crystallization of Glasses Produced by Milling Pharm. Res. 2012, 29 (4) 1020-1032
48. Trasi, N.; Byrn, S. Mechanically Induced Amorphization of Drugs: A Study of the Thermal Behavior of Cryomilled Compounds AAPS PharmSciTech 2012, 13 (3) 772-784